Letters Inhaled drugs and global warming

Cost of switching inhalers is high in carbon trading terms

BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f4162 (Published 02 July 2013) Cite this as: BMJ 2013;347:f4162
  1. Carl J Reynolds, core medical trainee1
  1. 1Royal Brompton Hospital, London SW3 6NP, UK
  1. carl.reynolds{at}openhealthcare.org.uk

The health risks from global climate change loom large,1 and actionable information about countermeasures is urgently needed.

Hillman and colleagues highlight the role of hydrofluorocarbons in metered dose inhalers (MDIs) as important greenhouse gases.2 They also note the variation in the proportion of inhalers that contain hydrofluorocarbons between the UK and Sweden. Our analysis using GP prescribing data for …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe